Adam Maeder
Stock Analyst at Piper Sandler
(1.54)
# 1413
Out of 5,328 analysts
136
Total ratings
51.72%
Success rate
8.60%
Average return
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
RMD ResMed | Maintains: Neutral | 260 248 | 236.53 | 4.85% | 3 | Apr 24, 2025 | |
EW Edwards Lifesciences | Upgrades: Overweight | 73 80 | 75.51 | 5.95% | 14 | Apr 24, 2025 | |
ISRG Intuitive Surgical | Maintains: Overweight | 670 575 | 515.83 | 11.47% | 19 | Apr 23, 2025 | |
ABT Abbott Laboratories | Reiterates: Overweight | 133 145 | 130.7 | 10.94% | 3 | Apr 17, 2025 | |
RXST RxSight | Initiates Coverage On: Neutral | 18 | 14.71 | 22.37% | 1 | Apr 15, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 11 9 | 8.24 | 3.16% | 7 | Mar 18, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 260 233 | 158.18 | 47.3% | 14 | Feb 10, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 6 6 | n/a | n/a | 16 | Feb 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 52 80 | n/a | n/a | 7 | Jan 7, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 5 5 | 2.59 | 73.75% | 3 | Sep 17, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 20 21 | 11.44 | 83.57% | 2 | May 22, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 18 20 | n/a | n/a | 6 | May 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 290 360 | n/a | n/a | 10 | Apr 2, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 7 8 | 4.37 | 83.07% | 1 | Mar 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 15 20 | 6.09 | 228.41% | 8 | Mar 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 75 71 | n/a | n/a | 8 | Jan 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 25 30 | 14.14 | 112.16% | 2 | May 9, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 6 5 | 2 | 150% | 2 | Mar 6, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 10 18 | 1.68 | 971.43% | 2 | Jan 6, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 104 99 | 37.06 | 167.13% | 3 | May 5, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 9 11 | n/a | n/a | 5 | Jun 14, 2021 |